2024
- Spark Therapeutics Community Letter
- November 2024: HDSA Today Newsletter
- Championing Hope: HDSA’s Unwavering Commitment to Huntington’s Disease Families
- October 2024 HDSA TODAY Newsletter
- 2023 HDSA Annual Report
- BLOG: This Week in HD Research
- We Need Your Voice! Take The HD Symptoms And Treatment Impact Survey
- HUNTINGTON’S DISEASE SOCIETY OF AMERICA AWARDS TWO 2024 BERMAN-TOPPER FAMILY HD CAREER DEVELOPMENT FELLOWSHIPS
- HDSA Awards Six 2024 Donald A. King Summer Research Fellowships
- uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
- Farewell & Leadership Transition at HDSA
- Wave Life Sciences Update: Results from SELECT-HD Community Letter
- PTC Therapeutics Update: Interim PIVOT-HD Results Community Letter
- HDSA Podcast- New Episode Now Available!
- A message from Louise Vetter, President & CEO
- Huntington’s Disease Awareness Month: A Month-Long Campaign to Educate and Empower, Culminating with the Annual HDSA Convention in Spokane, WA
- HDSA to Host Externally-led Patient Focused Drug Development (PFDD) Meeting
- Now Accepting Human Biology Project LOIs
- Act Fast: Early Bird Rate for HDSA Convention Ends March 31st!
- HDSA Publishes 2023 Year in Review
- Prilenia has shared a community letter announcing that they plan to take steps toward applying to the European Medicines Agency for approval of pridopidine.
- HUNTINGTON’S DISEASE SOCIETY OF AMERICA AWARDS MORE THAN $2.1 MILLION TO EXPAND HDSA CENTERS OF EXCELLENCE NETWORK TO SIXTY-EIGHT SITES
- 2024 DONALD A. KING SUMMER RESEARCH FELLOWSHIP APPLICATION NOW OPEN
- 2024 HDSA BERMAN/TOPPER FAMILY HD CAREER DEVELOPMENT FELLOWSHIP APPLICATION NOW OPEN
